Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
10/11/2011 | CA2468258C Peptide agonists of prostate-specific antigen, and uses therefor |
10/11/2011 | CA2465327C Nonhuman model animal of th2-mediated hyperimmune response |
10/11/2011 | CA2442993C Nucleic acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer |
10/11/2011 | CA2430314C Gene encoding acetolactate synthase |
10/11/2011 | CA2363971C A method for producing preparations of mature and immature pancreatic endocrine cells, the cell preparation and its use for treatment of diabetes mellitus |
10/11/2011 | CA2362658C In vitro production of transplantable cartilage tissue |
10/11/2011 | CA2362098C Human polyclonal antibodies from genetically engineered animals |
10/11/2011 | CA2336743C Antigenic peptides derived from telomerase |
10/11/2011 | CA2315017C Novel egiii-like enzymes, dna encoding such enzymes and methods for producing such enzymes |
10/11/2011 | CA2157932C Production of human papillomavirus capsid protein and virus-like particles |
10/06/2011 | WO2011123779A1 Cell therapy to improve wound healing and related compositions and methods |
10/06/2011 | WO2011123708A2 Genetic engineering of non-human animals for the production of chimeric antibodies |
10/06/2011 | WO2011123572A1 Reprogramming cells |
10/06/2011 | WO2011123213A1 Methods of multiplying plant embryogenic tissue in a bioreactor |
10/06/2011 | WO2011123166A2 Methods and systems for reducing dna fragmentation in a processed sperm sample |
10/06/2011 | WO2011123038A1 Method for maturing and synchronizing conifer somatic embryos. |
10/06/2011 | WO2011122889A2 Method for inhibiting the senescence of adult stem cells by inhibiting mirna expression |
10/06/2011 | WO2011122611A1 Cancer vaccine |
10/06/2011 | WO2011122601A1 Intervertebral disc nucleus pulposus stem/progenitor cell, method for culturing same, and application |
10/06/2011 | WO2011122318A1 Therapeutic graft material and method for using same |
10/06/2011 | WO2011122127A1 Peptide having osteoblast proliferation promotion activity and use thereof |
10/06/2011 | WO2011121768A1 Novel cellulase gene |
10/06/2011 | WO2011121636A1 Method for producing induced pluripotent stem cells |
10/06/2011 | WO2011121158A2 Method for obtaining oligodendrocyte precursor cells |
10/06/2011 | WO2011096894A3 Use of novel markers of pluripotent stem cells |
10/06/2011 | WO2011063005A3 Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells |
10/06/2011 | US20110247105 Osteospermum and dimorphoteca plants having an altered flower phenotype |
10/06/2011 | US20110247104 Homologous recombination-mediated transgene deletion in plant cells |
10/06/2011 | US20110247103 Methods for using artificial polynucleotides and compositions thereof to reduce transgene silencing |
10/06/2011 | US20110247102 Constitutive promoters from poplar and uses thereof |
10/06/2011 | US20110247101 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics |
10/06/2011 | US20110247100 Plant peptide gamma-zein for delivery of biomolecules into plant cells |
10/06/2011 | US20110247099 Genetic transformation of jatropha curcas |
10/06/2011 | US20110247098 Plants Having Enhanced Abiotic Stress Tolerance and/or Enhanced Yield-Related Traits and a Method for Making the Same |
10/06/2011 | US20110247097 Plants having modified growth characteristics and a method for making the same |
10/06/2011 | US20110247094 Transgenic Plants with Enhanced Agronomic Traits |
10/06/2011 | US20110247092 Osteospermum and dimorphoteca plants having an altered flower phenotype |
10/06/2011 | US20110247091 Transgenic Cells and Chickens Expressing RIG-I |
10/06/2011 | US20110247090 Synthetic 5'UTRs, Expression Vectors, and Methods for Increasing Transgene Expression |
10/06/2011 | US20110247088 Tetracycline inducible transcription control sequence |
10/06/2011 | US20110247087 Regulation of endogenous gene expression in cells using zinc finger proteins |
10/06/2011 | US20110245470 Immunoglobulins |
10/06/2011 | US20110245351 Medical adhesive for surgery |
10/06/2011 | US20110245329 Double-stranded rna structures and constructs, and methods for generating and using the same |
10/06/2011 | US20110245325 Pharmaceutical composition for treatment of cancer and asthma |
10/06/2011 | US20110245318 Rna sequence-specific mediators of rna interference |
10/06/2011 | US20110245311 Histidine Derivatives |
10/06/2011 | US20110245307 Methods for Alzheimer's Disease Treatment and Cognitive Enhancement |
10/06/2011 | US20110245251 Modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto |
10/06/2011 | US20110245220 Compounds and compositions as modulators of gpr119 activity |
10/06/2011 | US20110245217 Methods for diagnosing and treating asthma |
10/06/2011 | US20110245207 Method for moderately increasing the proton conductivity of biological membranes with the aid of mitochondria-targeted delocalized cations |
10/06/2011 | US20110245186 Recombinant e-selectin made in insect cells |
10/06/2011 | US20110245185 APO-2 ligand/trail formulations |
10/06/2011 | US20110245178 Exendin Fusion Proteins |
10/06/2011 | US20110245175 INHIBITING INTERACTION BETWEEN THE HIF-1ALPHA AND p300/CBP WITH HYDROGEN BOND SURROGATE-BASED |
10/06/2011 | US20110245168 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
10/06/2011 | US20110245167 NaK-ATPase-Derived Peptide SRC Inhibitors and Ouabain Antagonists and Uses Thereof |
10/06/2011 | US20110245107 Selective differentiation, identification, amd modulation of human th17 cells |
10/06/2011 | US20110244574 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva) |
10/06/2011 | US20110244573 Method For The Supply Of Growth Components To Cell Cultures |
10/06/2011 | US20110244572 Flat microfibers as matrices for cell growth |
10/06/2011 | US20110244571 Cell growth |
10/06/2011 | US20110244570 Volume exclusion agent to enhance formation of extracellular matrix |
10/06/2011 | US20110244569 Method of inducing proliferation and/or differentiation of neural precursor cells by introducing prolactin or wnt3a to activate latent neural precursor cells |
10/06/2011 | US20110244568 Rna sequence-specific mediators of rna interference |
10/06/2011 | US20110244567 Device and Method of 3-Dimensionally Generating IN VITRO Blood Vessels |
10/06/2011 | US20110244566 Enhanced efficiency of induced pluripotent stem cell generation |
10/06/2011 | US20110244565 Method Of Collecting Particles From A Sample Fluid |
10/06/2011 | US20110244564 Cystine knot molecules |
10/06/2011 | US20110244563 Assays that use the t1r1 receptor polypeptides to screen for t1r1-associated taste modulators |
10/06/2011 | US20110244562 Rna interference suppression of neurodegenerative diseases and methods of use thereof |
10/06/2011 | US20110244561 siRNA-MEDIATED GENE SILENCING |
10/06/2011 | US20110244548 DNA Polymerases Having Improved Labeled Nucleotide Incorporation Properties |
10/06/2011 | US20110244514 Mammalian Sweet Taste Receptors |
10/06/2011 | US20110244513 Isolated mammalian membrane protein genes; related reagents |
10/06/2011 | US20110244507 USE OF NEUREGULIN-ß AS AN INDICATOR AND/OR TARGET |
10/06/2011 | US20110244502 Hormone responsive tissue culture system and uses thereof |
10/06/2011 | US20110244501 Cancer stem cells |
10/06/2011 | US20110244496 Hiv reverse transcriptase compositions and methods |
10/06/2011 | US20110244487 Methods for testing binding of a ligand to a g protein-coupled receptor |
10/06/2011 | US20110244485 Anti-tuna vasa antibody |
10/06/2011 | US20110244474 Rapid screening of biologically active nucleases and isolation of nuclease-modified cells |
10/06/2011 | US20110244472 Cancer stem cell immortalization |
10/06/2011 | US20110244470 Isolated transgenic mammalian neural cell for detection of a sample containing a chemical substance damage to neurological system or selection of drugs for treating neurodegenerative disorders |
10/06/2011 | US20110244450 Primate totipotent and pluripotent stem cells produced by somatic cell nuclear transfer |
10/06/2011 | US20110244446 Rna sequence-specific mediators of rna interference |
10/06/2011 | US20110244443 Methods, Systems and Devices for Separating Tumor Cells |
10/06/2011 | US20110244025 Modified oligoribonucleotide analogs with enhanced immunostimulatory activity |
10/06/2011 | US20110244003 Self Standing Nanoparticle Networks/Scaffolds with Controllable Void Dimensions |
10/06/2011 | US20110243995 Method for Rational Mutagenesis of Alpha/Beta T-Cell Receptors and Correspondingly Mutated MDM2-Protein Specific Alpha/Beta T-Cell Receptors |
10/06/2011 | US20110243986 Polynucleotides allowing the expression and secretion of recombinant pseudo-virus containing foreign epitopes, their production, and use |
10/06/2011 | US20110243973 Hig2 and urlc10 epitope peptide and vaccines containing the same |
10/06/2011 | US20110243968 Therapeutic applications of p53 isoforms in regenerative medicine, aging and cancer |
10/06/2011 | US20110243967 Molecular complexes which modify immune responses |
10/06/2011 | US20110243966 SINGLE CHAIN Fc (ScFc) REGIONS, BINDING POLYPEPTIDES COMPRISING SAME, AND METHODS RELATED THERETO |
10/06/2011 | US20110243965 Antibodies against domains of laminin-332 |
10/06/2011 | US20110243963 Antibodies to lrp6 |
10/06/2011 | US20110243962 Therapeutic use of specific ligand in msrv associated diseases |
10/06/2011 | US20110243957 Materials and methods for preventing or treating neurodegenerative conditions associated with abeta peptide accumulation |